In-vitro and in-vivo respiratory deposition of a developed metered dose inhaler formulation of an anti-migraine drug

In-vitro and in-vivo respiratory deposition of a developed metered dose inhaler formulation of an anti-migraine drug

Enhancement of zolmitriptan bioavailability through development of micronized zolmitriptan pressurized metered dose inhaler (MDI) as an alternative to its traditional drug delivery systems. A reversed phase HPLC method for zolmitriptan determination was developed and evaluated. Micronized zolmitript...

Full description

Bibliographic Details
Main Authors: Ebtsam M. Abdou, Soha M. Kandil, Amany Morsi, Maysa W. Sleem
Format: Article
Language:English
Published: Taylor & Francis Group 2019-01-01
Series:Drug Delivery
Subjects:
anti-migraine
hfa propellant
metered dose inhaler
next generation impactor
zolmitriptan
Online Access:http://dx.doi.org/10.1080/10717544.2019.1618419

Similar Items

Similar Items